一个13岁的女性患有支气管癌症的儿科治疗术
Justine Trpezanovski1, Jonathan Karpelowsky2,3, Elizabeth Hesketh4
1Department of Nuclear Medicine, The Children's Hospital at Westmead, Sydney Children's Hospitals Network, Westmead, Sydney, NSW, Australia.
用 (177Lu) Lu-DOTA-TATE (LuTATE) 进行受体放射性核酸治疗 (PRRT) 对儿科支气管癌类瘤显示有前景. 这种方法可能有助于在手术前缩小瘤,改善年轻患者的治疗结果.
科学领域:
- 儿科瘤学 儿科瘤学
- 核医学是一种核医学.
- 放射性药物疗法是一种放射性药物疗法.
背景情况:
- 儿科支气管癌类瘤很少见,但占儿童肺癌的很大一部分.
- 这些神经内分泌瘤可以分泌ACTH,导致诸如库辛综合征之类的疾病.
- 大多数瘤中的索马托斯塔丁受体表达使它们成为向放射性核酸治疗的候选者.
研究的目的:
- 报告一例患有支气管癌类瘤的儿科患者,该患者接受了新辅助剂LuTATE的治疗.
- 为了评估多循环,高剂量的LUTATE治疗在儿科环境中的安全性和有效性.
- 评估LuTATE在减缓瘤和降低外科手术发病率方面的潜力.
主要方法:
- 一名13岁的女性患有确定的G1肺癌类瘤,接受了四次LuTATE循环.
- 剂量计计算指导剂量升级,重点关注安全的脏辐射暴露.
- 图像和活检用于初步诊断和反应评估.
主要成果:
- 患者在结节转移中表现出显著的代谢反应,在原发性瘤中表现出部分反应.
- 酸治疗耐受性很好,没有严重的并发症.
- 在整个治疗过程中,对脏的剂量进行了监测,以确保安全.
结论:
- 以剂量计为指导的LuTATE疗法是儿科支气管癌类瘤的可行和安全的治疗选择.
- 新辅助剂LUTATE可以促进瘤下降阶段,并减少儿科患者的手术并发症.
- 这一案例支持将LuTATE纳入罕见儿科肺癌的多学科治疗计划.
更多相关视频
07:30Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
Published on: May 4, 2022
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
相关概念视频
Trachea
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Pulmonary Cycle: Exhalation
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II
Clinical Manifestations:
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
